Abstract
Chemoembolization and percutaneous radiofrequency are complementary treatments for hepatocellular carcinoma (CHC). Their indications are to be regularly revalued according to the evolution of the disease: the first one is indicated in multiple but limited number lesions in patients with preserved hepatic functions. The use of microparticles did not allow to obtain an advance on the long-term survival, but standardize the method. Radiofrequency is a curative treatment, with several different devices, mono- or multipolar technologies. It preserved functional hepatic tissue and has for advantage its low rate of complications in patients in a fragile state.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
